Zydus Lifesciences has enclosed a copy of press release dated July 31, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Mamitra (Trastuzumab biosimilar) to treat various cancers’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.